Metabolic basis of HIV-lipodystrophy syndrome (Q44058330)

29 November 2017

title

Metabolic basis of HIV-lipodystrophy syndrome (English)

1 reference

29 November 2017

Rajagopal V Sekhar

1

1 reference

29 November 2017

Farook Jahoor

2

1 reference

29 November 2017

A Clinton White

3

1 reference

29 November 2017

Henry J Pownall

4

1 reference

29 November 2017

Fehmida Visnegarwala

5

1 reference

29 November 2017

Maria C Rodriguez-Barradas

6

1 reference

29 November 2017

Morali Sharma

7

1 reference

29 November 2017

Peter J Reeds

8

1 reference

29 November 2017

Ashok Balasubramanyam

9

1 reference

29 November 2017

publication date

1 August 2002

1 reference

American Journal of Physiology - Endocrinology and Metabolism

29 November 2017

published in

1 reference

29 November 2017

volume

283

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

E332-7

1 reference

Sodium oleate dissociates the heteroexchange of cholesteryl esters and triacylglycerol between HDL and triacylglycerol-rich lipoproteins

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Protease inhibitors in HIV infection. Lipodystrophy may be a consequence of prolonged survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Calculation of substrate oxidation rates in vivo from gaseous exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

A mass spectrometric method for measuring glycerol levels and enrichments in plasma using 13C and 2H stable isotopic tracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Isotopic determination of organic keto acid pentafluorobenzyl esters in biological fluids by negative chemical ionization gas chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Pseudo‐Cushing's Syndrome in Human Immunodeficiency Virus– Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Metabolic effects of indinavir in healthy HIV-seronegative men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Effects of oleic acid on the biosynthesis of lipoprotein apoproteins and distribution into the very-low-density lipoprotein by the isolated perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Indinavir-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

Inhibition of adipocyte differentiation by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPENDO.00058.2002

10.1152/AJPENDO.00058.2002

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference